reptile 发表于 2025-3-25 04:55:24
AR, Overview,Upon reactivation of AR-FL and expression of AR-Vs, traditional methods of treatment targeting the ligand binding domain are ineffective. Targeting the evolutionarily conserved N-terminal domain, DNA binding domain (DBD) or using transcription factors that interact with AR will be key in developing new treatments for PCa.Vital-Signs 发表于 2025-3-25 11:03:49
http://reply.papertrans.cn/23/2213/221211/221211_22.pngcorrespondent 发表于 2025-3-25 13:22:40
http://reply.papertrans.cn/23/2213/221211/221211_23.pngexclusice 发表于 2025-3-25 17:44:31
B-Raf, cancers. It is believed to be an early event since it is seen in the majority of nevi and a subset of premalignant colon polyps. Several kinase inhibitors targeting B-Raf are approved for advanced melanoma.VAN 发表于 2025-3-25 20:35:54
http://reply.papertrans.cn/23/2213/221211/221211_25.pngbleach 发表于 2025-3-26 01:28:51
CCL21,. Based on the findings on CCL21, it is anticipated that rational combinations with other treatment modalities will improve the therapeutic efficacy of this chemokine and antitumor benefit in a broad range of solid tumors.妈妈不开心 发表于 2025-3-26 07:27:28
http://reply.papertrans.cn/23/2213/221211/221211_27.pngmodest 发表于 2025-3-26 09:53:57
http://reply.papertrans.cn/23/2213/221211/221211_28.png药物 发表于 2025-3-26 13:16:27
http://reply.papertrans.cn/23/2213/221211/221211_29.png博爱家 发表于 2025-3-26 17:47:38
http://reply.papertrans.cn/23/2213/221211/221211_30.png